Live Cell Encapsulation Market Emerging Technology, Competitive Landscape by Regional Forecast to 2030
Live Cell Encapsulation Market Overview
Live cell encapsulation is the
process of combining cells and scaffolds for the transfer of medicines in the
human body. This can reduce the dependence on immunosuppressant drugs.
Development of biodegradable carriers can shape the future of cell discovery in
the coming years. Market Research Future (MRFR) in its cutting-edge report
states the development of live cell encapsulation in conjunction with various
pertinent developments. It highlights drivers, restraints, trends, and
opportunities for the period of 2022 to 2030 (forecast period).
The global Live Cell Encapsulation Market can register a CAGR of 3.60%
during the forecast period. Its value was USD 306.11 Million by 2030. The
market is primarily driven by awareness of clinical impacts of cell
encapsulation technologies and its role in the treatment of chronic diseases.
Development of bioencapsulation technologies for safe passage of therapeutic
agents to the host body is likely to lead the market in the years ahead. The
success in tissue and organ replacement is evident of the large potential of
the market.
Adoption of polymers for the manufacture of
scaffolds can work in favor of the market. For instance, biodegradable
hydrogels is likely to be heavily used in tissue engineering due to possessing
properties of diffusion, degradation, swelling, and other mechanical
properties. The ability to cover the shortage of donor organs using cell
therapy can widen the scope of the global live cell encapsulation market.Lack
of skilled technicians, lack of cash-crunch in small organizations, and
unavailability of raw materials are challenges faced by the market.
Live Cell
Encapsulation Market Segmentation
The global live cell encapsulation
market is segmented into manufacturing technique, polymer type, and
application.
By manufacturing technique, it is
segmented into rotating disk atomization, simple dripping, electrostatic
dripping, coaxial airflow, and others.
By polymer type, it is segmented
into silica, alginate, PAN-PVC, HEMA-MMA, Chitosan, cellulose sulfate, and
others.
Applications of the market
comprise cell transplantation, drug delivery, regenerative medicine, and
others. The drug delivery segment is expected to hold a major share owing to
the increasing use of live cell encapsulation techniques in drug delivery
systems. On the other hand, the regenerative medicine segment is expected to be
the fastest-growing in the market due to advances in tissue engineering.
Live Cell Encapsulation Market Regional Analysis
The market has been segmented, by
region, into the Americas, Europe, Asia Pacific (APAC), and the Middle East
& Africa (MEA).
The Americas will dominate the
global live cell encapsulation market owing to the large healthcare expenditure
and rapid adoption of the latest technology. The regional market can thrive due
to allocation of funds for research and development by government agencies.
Furthermore, applications of regenerative medicine which have encouraged the
outcomes of tissue implants can bode well for the market.
Europe has a considerable share
of the market owing to rise in cases of chronic diseases and a well-defined
healthcare framework. According to Cancer Research UK, there were close to
9,921 cases in 2015. The high numbers are bound to induce demand for cellular
research, monoclonal bodies, and next-generation sequencing.
APAC is projected to showcase a
positive growth rate due to healthcare reforms by governments and a surge
noticed in chronic disease cases. But low investments of capital may restrict
regional market growth. Lastly, the MEA has the lowest market share due to low
disposable income levels of patients, limited healthcare facilities, and
limited access to treatment.
Competition Outlook
Viacyte, Inc., Sigilon
Therapeutics, Inc., Balchem Corporation, Blacktrace Holdings Ltd., Lycored,
Merck KGaA, Neurotech Holdings, LLC, Living Cell Technologies, Encapsys, LLC,
MiKroCaps, BÜCHI Labortechnik AG, Reed Pacific Pty Limited, Evonik Industries,
Biotime, Inc., and Sernova Corporation are global live
cell encapsulation market Players. Collaborations are a prime strategy of
players in sustaining their market hold.
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and intelligence
services to our clients.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment